Eli Lilly And Stock Price History
LLY Stock | USD 777.96 0.22 0.03% |
Below is the normalized historical share price chart for Eli Lilly And extending back to June 01, 1972. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Eli Lilly stands at 777.96, as last reported on the 28th of March, with the highest price reaching 793.67 and the lowest price hitting 776.44 during the day.
If you're considering investing in Eli Stock, it is important to understand the factors that can impact its price. Eli Lilly appears to be very steady, given 3 months investment horizon. Eli Lilly And secures Sharpe Ratio (or Efficiency) of 0.29, which denotes the company had a 0.29% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Eli Lilly And, which you can use to evaluate the volatility of the firm. Please utilize Eli Lilly's Downside Deviation of 1.39, coefficient of variation of 330.92, and Mean Deviation of 1.13 to check if our risk estimates are consistent with your expectations.
Liabilities And Stockholders Equity is likely to rise to about 67.2 B in 2024, whereas Total Stockholder Equity is likely to drop slightly above 9 B in 2024. . At this time, Eli Lilly's Price Earnings Ratio is fairly stable compared to the past year. Price To Sales Ratio is likely to rise to 16.15 in 2024, despite the fact that Price Earnings To Growth Ratio is likely to grow to (5.94). Eli Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of January 1978 | 200 Day MA 589.5485 | 50 Day MA 725.0472 | Beta 0.344 |
Eli |
Sharpe Ratio = 0.292
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | LLY | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.64 actual daily | 14 86% of assets are more volatile |
Expected Return
0.48 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
0.29 actual daily | 22 78% of assets perform better |
Based on monthly moving average Eli Lilly is performing at about 22% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eli Lilly by adding it to a well-diversified portfolio.
Price Book 68.3954 | Enterprise Value Ebitda 88.5929 | Price Sales 21.5903 | Shares Float 897.9 M | Dividend Share 4.52 |
Eli Lilly Stock Price History Chart
There are several ways to analyze Eli Stock price data. The simplest method is using a basic Eli candlestick price chart, which shows Eli Lilly price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | March 4, 2024 | 792.28 |
Lowest Price | January 2, 2024 | 591.16 |
Eli Lilly March 28, 2024 Stock Price Synopsis
Various analyses of Eli Lilly's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Eli Stock. It can be used to describe the percentage change in the price of Eli Lilly from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Eli Stock.Eli Lilly Accumulation Distribution | 69,660 | |
Eli Lilly Price Daily Balance Of Power | (0.01) | |
Eli Lilly Price Rate Of Daily Change | 1.00 | |
Eli Lilly Price Action Indicator | (7.20) |
Eli Lilly March 28, 2024 Stock Price Analysis
Eli Stock Price History Data
The price series of Eli Lilly for the period between Fri, Dec 29, 2023 and Thu, Mar 28, 2024 has a statistical range of 222.89 with a coefficient of variation of 10.53. The daily prices for the period are spread out with arithmetic mean of 697.75. The median price for the last 90 days is 734.39. The company underwent 2:1 stock split on 16th of October 1997. Eli Lilly And issued dividends to stockholders on 2024-02-14.Open | High | Low | Close | Volume | ||
03/28/2024 | 780.32 | 793.67 | 776.44 | 777.96 | 3,208,759 | |
03/27/2024 | 778.71 | 785.26 | 767.38 | 778.18 | 2,297,320 | |
03/26/2024 | 774.20 | 778.33 | 769.00 | 774.90 | 2,098,739 | |
03/25/2024 | 771.10 | 778.49 | 768.15 | 773.14 | 1,805,679 | |
03/22/2024 | 770.00 | 777.00 | 767.28 | 770.61 | 1,979,927 | |
03/21/2024 | 774.00 | 780.54 | 758.88 | 770.26 | 3,011,915 | |
03/20/2024 | 770.11 | 773.16 | 756.64 | 772.86 | 2,036,662 | |
03/19/2024 | 758.44 | 773.85 | 755.00 | 772.78 | 2,555,226 | |
03/18/2024 | 762.28 | 769.68 | 758.25 | 762.66 | 2,520,606 | |
03/15/2024 | 755.38 | 760.89 | 747.71 | 754.17 | 3,729,352 | |
03/14/2024 | 764.95 | 768.00 | 749.40 | 760.73 | 2,646,822 | |
03/13/2024 | 757.00 | 760.77 | 745.71 | 757.84 | 2,357,345 | |
03/12/2024 | 740.96 | 755.97 | 738.01 | 754.95 | 2,699,885 | |
03/11/2024 | 752.21 | 756.80 | 727.62 | 734.37 | 3,968,233 | |
03/08/2024 | 780.00 | 780.00 | 755.00 | 762.14 | 4,052,825 | |
03/07/2024 | 771.84 | 792.99 | 761.12 | 780.16 | 3,974,330 | |
03/06/2024 | 784.29 | 787.85 | 774.00 | 779.77 | 2,503,797 | |
03/05/2024 | 785.31 | 788.53 | 769.28 | 777.59 | 3,166,757 | |
03/04/2024 | 796.44 | 800.78 | 786.16 | 792.28 | 3,850,735 | |
03/01/2024 | 769.02 | 784.08 | 764.13 | 782.12 | 4,243,924 | |
02/29/2024 | 753.08 | 756.46 | 744.03 | 753.68 | 3,902,643 | |
02/28/2024 | 762.25 | 763.00 | 751.66 | 757.64 | 2,714,921 | |
02/27/2024 | 754.90 | 772.95 | 745.44 | 765.00 | 2,715,647 | |
02/26/2024 | 771.30 | 780.22 | 769.12 | 771.92 | 2,242,093 | |
02/23/2024 | 774.00 | 777.65 | 762.26 | 769.54 | 2,393,772 | |
02/22/2024 | 763.58 | 775.12 | 756.27 | 769.64 | 3,163,139 | |
02/21/2024 | 738.08 | 749.50 | 733.24 | 745.91 | 3,545,868 | |
02/20/2024 | 790.00 | 793.38 | 753.20 | 755.66 | 4,698,459 | |
02/16/2024 | 771.03 | 794.47 | 763.50 | 782.06 | 5,005,340 | |
02/15/2024 | 755.80 | 762.99 | 750.01 | 757.78 | 2,506,721 | |
02/14/2024 | 745.82 | 764.05 | 745.00 | 757.31 | 3,392,682 | |
02/13/2024 | 730.18 | 742.98 | 730.18 | 741.67 | 2,860,265 | |
02/12/2024 | 740.80 | 740.80 | 726.45 | 735.97 | 2,932,304 | |
02/09/2024 | 735.50 | 745.70 | 733.61 | 738.86 | 2,833,900 | |
02/08/2024 | 728.32 | 741.00 | 725.75 | 734.39 | 4,636,900 | |
02/07/2024 | 710.38 | 740.99 | 707.02 | 724.11 | 5,798,000 | |
02/06/2024 | 742.00 | 742.00 | 691.10 | 703.80 | 8,187,300 | |
02/05/2024 | 691.02 | 711.88 | 682.53 | 704.96 | 7,602,400 | |
02/02/2024 | 662.38 | 672.62 | 659.74 | 666.48 | 3,018,000 | |
02/01/2024 | 647.33 | 660.52 | 643.17 | 659.27 | 2,494,300 | |
01/31/2024 | 650.38 | 663.55 | 637.00 | 644.48 | 4,719,000 | |
01/30/2024 | 645.70 | 646.80 | 641.00 | 643.85 | 2,006,100 | |
01/29/2024 | 641.50 | 645.65 | 639.77 | 643.87 | 2,718,500 | |
01/26/2024 | 637.35 | 639.60 | 630.50 | 638.13 | 2,410,300 | |
01/25/2024 | 627.37 | 632.61 | 624.68 | 626.52 | 2,407,900 | |
01/24/2024 | 633.52 | 643.17 | 632.00 | 632.59 | 2,276,900 | |
01/23/2024 | 627.69 | 630.00 | 614.82 | 628.58 | 2,525,000 | |
01/22/2024 | 630.00 | 632.64 | 625.00 | 629.78 | 2,030,200 | |
01/19/2024 | 622.39 | 629.59 | 620.00 | 627.48 | 3,120,500 | |
01/18/2024 | 621.28 | 623.88 | 612.70 | 622.26 | 3,385,000 | |
01/17/2024 | 639.45 | 640.52 | 625.19 | 627.81 | 2,124,100 | |
01/16/2024 | 643.91 | 647.73 | 633.46 | 633.46 | 2,413,600 | |
01/12/2024 | 638.20 | 644.00 | 633.01 | 641.80 | 2,066,400 | |
01/11/2024 | 634.39 | 639.76 | 628.14 | 634.61 | 2,690,300 | |
01/10/2024 | 628.49 | 637.05 | 625.76 | 629.09 | 2,679,100 | |
01/09/2024 | 630.11 | 634.42 | 623.72 | 624.39 | 2,918,900 | |
01/08/2024 | 622.43 | 626.06 | 609.59 | 624.93 | 2,453,900 | |
01/05/2024 | 614.00 | 619.94 | 610.19 | 617.47 | 2,402,500 | |
01/04/2024 | 625.26 | 636.41 | 613.27 | 613.42 | 6,272,500 | |
01/03/2024 | 600.00 | 619.84 | 598.80 | 616.62 | 5,130,300 | |
01/02/2024 | 580.41 | 592.72 | 579.05 | 591.16 | 3,226,700 |
About Eli Lilly Stock history
Eli Lilly investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eli is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eli Lilly And will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eli Lilly stock prices may prove useful in developing a viable investing in Eli Lilly
Last Reported | Projected for 2024 | ||
Common Stock Shares Outstanding | 903.3 M | 868.4 M | |
Net Income Applicable To Common Shares | 7.2 B | 4 B |
Eli Lilly Stock Technical Analysis
Eli Lilly technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
All Next | Launch Module |
Eli Lilly Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eli Lilly's price direction in advance. Along with the technical and fundamental analysis of Eli Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eli to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1744 | |||
Jensen Alpha | 0.4135 | |||
Total Risk Alpha | 0.1153 | |||
Sortino Ratio | 0.2499 | |||
Treynor Ratio | 0.9943 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly And. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Eli Stock analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Stocks Directory Find actively traded stocks across global markets | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Eli Lilly's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eli Lilly. If investors know Eli will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eli Lilly listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.13 | Dividend Share 4.52 | Earnings Share 5.81 | Revenue Per Share 37.908 | Quarterly Revenue Growth 0.281 |
The market value of Eli Lilly And is measured differently than its book value, which is the value of Eli that is recorded on the company's balance sheet. Investors also form their own opinion of Eli Lilly's value that differs from its market value or its book value, called intrinsic value, which is Eli Lilly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eli Lilly's market value can be influenced by many factors that don't directly affect Eli Lilly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.